Back to News
Market Impact: 0.2
4 Biotech Stocks Likely to Outpace Q3 Earnings Estimates
Source: Nasdaq
Healthcare & BiotechAnalyst EstimatesCorporate Earnings
Four biotech stocks, including TG Therapeutics and Immunome, have positive Earnings ESPs and favorable Zacks Ranks, which the article says position them for potential third-quarter earnings beats. The article identifies potential beats, not reported results or confirmed earnings surprises.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
IMNM0.30
TGTX0.30
More News
- Qualcomm issues disappointing earnings forecast as memory shortage weighs on smartphone sales
- ‘Seismic’ blue wave triggers the sinking of oil prices, energy stocks, and the chances of power permitting reform
- Nifty Bounces Back to Beat All of Asia on Foreign Flows, Earnings
- Snap shares fall over 10% on third-quarter earnings miss
- What Democrats’ midterm sweep means for your investments
- A blue wave sends futures into the green